Susquehanna International Group, LLP Vascular Biogenics Ltd. Transaction History

Susquehanna International Group, LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.21 - $0.32 $32,625 - $49,714	155,358 New	155,358 $37,000
Q2 2022 Aug 15, 2022	BUY	$1.22 - $1.95 $88,044 - $140,727	72,168 Added 662.88%	83,055 $134,000
Q4 2020 Feb 16, 2021	BUY	$1.07 - $2.0 $514 - $962	481 Added 4.62%	10,887 $21,000
Q2 2020 Aug 14, 2020	SELL	$1.12 - $1.63 $1,854 - $2,699	-1,656 Reduced 13.73%	10,406 $13,000
Q1 2020 May 15, 2020	BUY	$0.96 - $1.57 $11,579 - $18,937	12,062 New	12,062 $16,000
Q1 2019 May 15, 2019	SELL	$0.94 - $1.75 $18,777 - $34,958	-19,976 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.6 - $1.72 $5,486 - $15,727	9,144 Added 84.42%	19,976 $19,000
Q1 2018 May 15, 2018	SELL	$2.27 - $8.5 $11,429 - $42,797	-5,035 Reduced 31.73%	10,832 $25,000
Q4 2017 Feb 14, 2018	SELL	$5.65 - $9.0 $44,770 - $71,316	-7,924 Reduced 33.31%	15,867 $113,000
Q3 2017 Nov 14, 2017	BUY	$4.15 - $7.2 $98,732 - $171,295	23,791	23,791 $145,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.